Toth Financial Advisory Corp Logic Bio Therapeutics, Inc. Transaction History

Toth Financial Advisory Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$2.2 - $4.53 $330 - $679	-150 Closed	0 $0
Q3 2021 Oct 20, 2021	SELL	$3.85 - $5.09 $192 - $254	-50 Reduced 25.0%	150 $1,000
Q3 2020 Oct 16, 2020	BUY	$5.41 - $9.45 $270 - $472	50 Added 33.33%	200 $2,000
Q4 2019 Jan 27, 2020	BUY	$7.01 - $11.01 $1,051 - $1,651	150 New	150 $1,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.